State Street Corp
- SEC CIK
- 0000093751
- Latest filing
- Sep 22, 2026
VIRX holding history
Viracta Therapeutics, Inc. in every 13F filed by State Street Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VIRX overviewAll 13F holders of VIRXFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 15
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −65,867−100.0% | Sold out | Holders |
| Q4 2024 | 65,867 | $10.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 65,867 | $15.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 65,867 | $35.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 65,867 | $67.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 65,867 | $37.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 65,867 | $68.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 65,867 | $92.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 65,867 | $104.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 65,867 | $96.2K | <0.1% | +6,800+11.5% | Added | Holders |
| Q3 2022 | 59,067 | $252.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 59,067 | $229.0K | <0.1% | −529,536−90.0% | Reduced | Holders |
| Q1 2022 | 588,603 | $2.80M | <0.1% | +13,514+2.3% | Added | Holders |
| Q4 2021 | 575,089 | $2.10M | <0.1% | −2,463−0.4% | Reduced | Holders |
| Q3 2021 | 577,552 | $4.63M | <0.1% | +93,330+19.3% | Added | Holders |
| Q2 2021 | 484,222 | $5.49M | <0.1% | +484,222 | New | Holders |